Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease

H. Vlassara, J. Uribarri, W. Cai, S. Goodman, R. Pyzik, J. Post, F. Grosjean, M. Woodward, G. E. Striker
  • Clinical Journal of the American Society of Nephrology, March 2012, American Society of Nephrology
  • DOI: 10.2215/cjn.12891211

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Jaime Uribarri and Mark Woodward